How to Live to 150! (Interview with Christian Angermayer)
Why is Germany falling behind, and which technologies will change the world in the coming years? This conversation with ...
Founder, Apeiron Investment Group
Search every verified Christian Angermayer interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Christian Angermayer, founder of Apeiron Investment Group, discussed his views on longevity, psychedelics, and consumer biotech in recent podcast appearances. In an August 2026 interview, he stated that aging is an umbrella term for various health problems and that solving all cancers would only extend average human lifespan by about three and a half years. He also said loneliness is a bigger killer than war and argued that discipline, not money, is the key factor for a long life. Angermayer noted he has never consumed alcohol, smoked, or used recreational drugs, and described his early introduction to psychedelics through a scientist in 2013. In a July 2026 podcast, Angermayer commented on the rise of consumer biotech, citing GLP-1 drugs as a major driver of industry interest and noting that Eli Lilly became a trillion-dollar company partly due to weight-loss treatments. He predicted the next wave in consumer biotech would involve muscle-gain drugs, mentioning his portfolio company Cambrian and its announced Phase 2 trial for an activin receptor antagonist. He also criticized the glorification of sleep deprivation, recommending adequate sleep as non-negotiable for performance. In earlier remarks, he expressed skepticism about the speed of AI in drug development, saying it can streamline preclinical work but will not dramatically shorten clinical timelines.
Why is Germany falling behind, and which technologies will change the world in the coming years? This conversation with ...
My guest this week is Christian Angermayer. Christian is a friend and definitely the most interesting person I know. He has founded and invested in businesses in some of the most fascinating and mind-blowing areas from space tech to fintech to biotech, crypto - you name it he’s in there. He has become one of the largest investors in the psychedelic space and is on a mission to cure mental health disorders and addiction. Christian is the founder of Apeiron Investment Group (www.apeiron-investments.com). Apeiron focuses on BioTech, FinTech & Crypto and DeepTech investments. Christian has (execut…
Christian Angermayer became a multimillionaire before turning 25 thanks to the merger of Alnylam with Ribopharma. We talk about his diverse investment appetite and the rise of consumer biotech and human enhancement. We talk about GLP-1s, the progress of AtaiBeckley, and why he thinks ‘going home and sleeping’ beats an all-nighter every time. --- Discover the best biotech companies in 🇪🇺 with the FlotBio Map at https://bit.ly/4nXmKjN --- ⭐️ ABOUT THE SPEAKER Christian is the founder of Apeiron Investment Group, which manages around $7 billion across psychedelics, longevity, consumer biote…
Psychedelics allow you to communicate with the divine, Christian Angermayer, founder of the Enhanced Games, tells the columnist Ross Douthat on “Interesting Times,” arguing that the safe use of certain mind-altering drugs should be part of living a full life. Watch the full episode: • Better Sex, Better Hair, Better Sleep: ‘Hu...
On this special bonus episode of the Strong New York Podcast, Christian Angermayer, founder of the Enhanced Games, a new global sports competition, joins Kenny Santucci just 48 hours after the inaugural event in Las Vegas to break down what really happened — the world record, the $10 million bounty to beat Usain Bolt's 100m record, the Fred Kerley controversy, and why 21 athletes hit personal bests under medical supervision. Christian is a billionaire biotech investor and one of the loudest voices advocating for the future of human performance and psychedelic medicine. In this episode, we ge…
This week on Generating Alpha, I sat down with Christian Angermayer — serial entrepreneur, biotech pioneer, and founder of Apeiron Investment Group, one of the most unconventional private investment firms in the world. Christian grew up in a small town in Bavaria and dropped out of university at 20 to co-found Ribopharma, a biotech built on groundbreaking RNA interference technology. He sold it to Alnylam Pharmaceuticals before turning 25, and has spent the two decades since founding three unicorns, backing four more, and completing over 50 IPOs and M&A transactions across life sciences, fint…
Lydia Moynihan sits down with Christian Angermayer and Max Martin to discuss the controversial vision behind the Enhanced Games. They debate whether performance-enhancing drugs in sports should remain banned, how FDA-approved substances are already being used across society, and why they believe the future of athletics will prioritize optimization, recovery, and longevity. The conversation also dives into peptides, GLP-1s, athlete compensation, biohacking culture, and the growing movement around “human enhancement.” Plus, they explain why investors like Peter Thiel are backing the project — an…
Christian Angermeyer joins Plausibly Deniable to discuss the Enhanced Games, performance-enhancing drugs, psychedelic medicine, longevity, telehealth, ambition, and building companies around controversial ideas before they become mainstream. Christian argues that the debate around performance enhancement is stuck in moral panic, bad incentives, and missing data. He explains why the Enhanced Games are designed not just as a sports spectacle, but as a research and media platform: athletes competing with medically supervised enhancement, data being collected at scale, and a broader business buil…
Christian Angermayer, Founder and Chairman of AtaiBeckley Inc. joins AlphaNooner to break down what’s actually changing in psychedelics in 2026. From advancing clinical programs and upcoming data readouts to increasing pharma interest and a shifting regulatory backdrop, the conversation focuses on what’s real, what’s noise, and where the space is heading next. $ATAI has been at the center of the industry’s evolution, and this discussion looks at how the business is positioning for the next phase of growth as psychedelics become scalable, medically accepted treatments. Tune in for the AlphaN…
Christian Angermayer plant eine "Doping-Olympiade", will Dinosaurier zum Leben erwecken und arbeitet daran, bis zu 200 Jahre alt zu werden: Der Deutsche zählt zu den schillerndsten Investoren der Welt, verwaltet mit seiner Apeiron Investment Group ein Milliarden-Vermögen und ist in den Top-Zirkeln der Welt bestens vernetzt. Im OMR Podcast erzählt er von Treffen mit Donald Trump und erklärt, warum er den Kurs der US-Regierung in vielen Punkten richtig findet. Und zum Schluss verrät der Mann, der von Testosteron als Biohacking-Routine bis hin zu Magic-Mushroom-Trips kaum etwas auslässt, welches…
Christian Angermayer, founder of Apeiron Investment Group, and Anne Philippi, founder of the New Health Club, explore the rapid evolution of human enhancement technologies, from psychedelics to performance-enhancing drugs. Angermayer introduces the Enhanced Games, a global sports event where performance-enhancing drugs are openly endorsed to push the boundaries of human potential. He argues that this transparent approach levels the playing field while offering athletes better compensation and recognition – an alternative to the restrictive practices of traditional sports organizations like t…
Governments steal your life's work through currency debasement. Your ego steals your peace. Christian Angermayer, the German ...
“The real factor for a long life is not money, it's discipline. Everything I just told you, anyone can do with discipline.”
“Loneliness is a bigger killer than war. If we solved all cancers today, we would on average only live three and a half years longer as humanity, because then other problems come.”
“All politicians from left and right from any part of the spectrum decided that money printing is the thing to go. So, we're going to see this massive devaluation of fiat money. And never before, again, I really love history and normally this happened to one currency or one country or whatever. At the moment, it's happening to all the major currencies in the world.”
“I think the next big wave in consumer biotech will be muscle gain drugs where you... there's already the big talk about retardite because you don't lose muscles because all the GLP1 so far had a little bit in average... lose muscle mass but like retardite is not doing that but like we have actually a portfolio company Cambrian and we just announced we found are we going into phase two with a drug it's ank activator w”
“Lily became a trillion dollar company. It's the first company because of weight loss. And now all the biotech and farmer industry is waking up and it's like wow there is a lot of money in vanity in consumer biotech and and here we are.”
“We increased the bounty for breaking the 100 meter man's sprint world record of St. B to $10 million. Why? Also because in sprint so athletes in the Olympic system are terribly paid. The one few exemptions we're literally talking about 10 people are the the famous sprinters. Yeah. And so we acknowledge to entice them to take that step which has always risks reputation risk for them. Yeah. I don't think factually, but”
Sign in to search the full transcript archive, filter by topic, and access every quote from Christian Angermayer.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans